SHANGHAI FOSUN PHARMACEUTICAL GROUP
(HKEX: 2196)

Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. The Healthcare Service segment provides healthcare service and hospital management. The Medical Devices and Medical Diagnosis segment focuses on the production and sale of medical equipment and diagnostic products. The Pharmaceutical Distribution and Retail segment issue retail and wholesale of medicine. The Other Business Operations segment comprises business that is different from the role of other segments. The company was founded on January 14, 1994 and is headquartered in Shanghai, China.

13.840 -

-0.120 (-0.86%)
Range 13.840 - 14.040   (1.45%)
Open 14.000
Previous Close 13.960
Bid Price 13.840
Bid Volume ('000) 65.5
Ask Price 13.860
Ask Volume ('000) 4
Volume ('000) 2,974
Value 41,343,107
Remark -
Delayed prices. Updated at 20 Dec 2024 16:08.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis